There is a global need to identify individuals at risk for osteoporotic fracture so that those at high risk can be treated and unnecessary treatment for those at low risk can be avoided. Bone mineral density (BMD) information is not sufficient to identify patients at high risk; approximately ...
Information for patients In addition to the release of the report, the Surgeon General has published a companion “People’s Piece” specifically written for patients. The magazine-style, full-color booklet offers ready-to-use information on how people can improve their bone health. www.surgeongen...
Zoledronate (Reclast):This is a powerful intravenous bisphosphonate that is given once a year. This can be especially beneficial for patients who cannot tolerate oral bisphosphonates or are having difficulty complying with the required regular dosing of oral medications. Other hormones:These hormones he...
London Osteoporosis Clinic offers expert osteoporosis treatment and support for patients with osteoporosis and related bone conditions.
7-10 In addition, the ACR has recently developed recommendations for the prevention and treatment of osteoporosis in corticosteroid treated patients.11 In contrast, no consensus or guidelines exist for the prevention and treatment of osteoporosis in patients with rheumatoid arthritis (RA), although ...
For the treatment ofpostmenopausal women with osteoporosisat high risk for fracture Help lead your patients to stronger bones with Prolia®1,2 WHO TO TREAT Consider which of your patients may be ready to start on Prolia®. Learn More ...
Great for the mind body and soul, it's easy to see how zumba has gathered its international following. For women going through menopause, the Latin dance party workout provides the perfect opportunity to increase bone density and reduce the risk of osteoporosis. For more information, check out...
BACKGROUND: Patients who survive hip fracture are at high risk of recurrent fractures, but rates of osteoporosis treatment 1 year after sustaining a fractu... SR Majumdar,LA Beaupre,CH Harley,... - 《Archives of Internal Medicine》 被引量: 211发表: 2007年 Treatment of Osteoporosis: Are Physi...
Raloxifene also is a weaker medication for improving bone density or preventing fractures as compared to estrogen or bisphosphonates. In patients with moderate to severe osteoporosis, it is advisable to use the more potent antiresorptive medications (bisphosphonates). In addition, the safety and ...
Some third parties are outside of the European Economic Area, with varying standards of data protection. See our privacy policy for more information on the use of your personal data. Manage preferences for further information and to change your choices. Accept all cookies ...